Dynamics of bone remodelling: Biochemical and pathophysiological basis

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 9, 1996, Pages 729-734

  De Vernejoul, Marie Christine ^a,b  

^a CENTRE VIGGO PETERSEN   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; HORMONE; INTERLEUKIN 6;

ANIMAL EXPERIMENT; BONE ATROPHY; BONE MATRIX; BONE REMODELING; CELL COMMUNICATION; CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; MOLECULAR DYNAMICS; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGING; ANIMALS; BONE REMODELING; CYTOKINES; ESTRADIOL; FEMALE; HUMANS; MICE; MODELS, MOLECULAR; OSTEOCLASTS; OSTEOGENESIS; SOMATOMEDINS;

EID: 0029736445     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Baron R, Chakhraborty M, Chatterjee D, Hörne W, Lomri D, Ravesboot JH. Biology of the osteoclast. In: Mundy GR, Martin TJ, editors. Handbook of experimental pharmacology. Berlin: Springer, 1993; 107:111-48.
2. Aubin JE, Heersche JNM, Bellows CG, Grigoriadis AE. Osteoblast lineage analysis in fetal rat calvarial cells. In: Cohn DV, Glorieux FH, Martin TJ, editors. Calcium regulation and bone metabolims. Amsterdam: Elsevier, 1990:362 -70.
3. Stein GS, Lian JB, Gerstenfeld LG, Shalhoub V, Aronow M, Owen T, et al. The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. Connect Tissue Res 1989; 20:3-13.
4. de Vernejoul MC, Marie P. Cellules osseuses et remodelage osseux. Médecine et Science 1993; 11:1192-203.
5. Ernst M, Heath JK, Schmid C, Froesch RE, Rodan GA. Evidence for a direct effect of estrogen on bone cells in vitro. J Steroid Biochem 1989; 34:279-84.
6. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Speisberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sei USA 1991; 88:6613-7.
7. Martin TJ, Ng KW. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 1994; 56:357-66.
8. Roodman GD. Interleukin-6: an osteotrophic factor? J Bone Mineral Res 1992; 7:475-8.
9. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, et al. 17-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89:883-91.
10. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257:88-91.
11. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13:118996.
12. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 and tumor necrosis factor-a: lack of regulation by 17-estradiol. Endocrinol 1992; 130:2528-34.
13. Rickard D, Rüssel G, Gowen M. Estradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporosis Int 1992; 2:94-102.
14. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL et al. Modulation of transforming growth factor- production in normal human osteoblast-like cells by 17-estradiol and parathyroid hormone. Endocrinology 1991; 129:3312-20.
15. Finkelman RD, Bell NH, Strong DD, Kemers LM, Baylink DJ. Ovariectomy selectively reduces the concentration of transforming growth factor in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sei USA 1992; 129:3313-20.
16. Beaudreuil J, Mbalaviele G, Cohen-Solal M, Morieux C, de Vernejoul MC, Orcel Ph. Short-term local injections of transforming growth factor l decrease ovariectomy-stimulated osteoclastic résorption in vivo in rats. J Bone Miner Res 1995; 10:971-7.
17. Pacifici R. Is there a causal role for IL-1 in postmenopausal bone loss? Calcif Tissue Int 1992; 50:295-9.
18. Cohen-Solal M, Graulet AM, Denne MA, Guéris J, Baylink D, de Vernejoul MC. Peripheral monocyte culture supernatants of menopausal women can induce bone résorption involvement of growth factors. J Clin Endocrinol Metab 1993; 77:1648-53.
19. Cohen-Solal ME, Graulet AM, Guéris J, Denne MA, Bergot C, Morieux C, et al. Bone résorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal women an in vitro-in vivo study. J Bone Mineral Res 1995; 10:307-15.
20. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science (Wash DC) 1993; 260:626-7.
21. Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, et al. Determinants of total body and regional bone mineral density in normal postmenopausal women - A key role for fat mass. J Clin Endocrinol Metab 1992; 75:45.
22. Quesada M, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R. Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992; 75:494-501.
23. Marie PJ, de Vernejoul MC, Connes D, Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest 1991; 88:1167-72.
24. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, et al. Age-related decreases in insulin-like growth factor-I and transforming growth factor- in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 1994; 78:1011.
25. Johansson AG, Lindh E, Ljunghall S. Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 1992; 339:1619.
26. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 1993; 77:1384.
27. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, et al. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinol 1992; 131:1075.
28. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, et al. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 1992; 74:24-7.